In Historic Vote, New Zealand Bans Software Patents
My two cents: A computer program is “not an invention.” The bill only applies to new patents and there is some ambiguity as to what it covers, but it will be interesting to see if this is the beginning of a trend. Will other countries follow New Zealand’s lead?
—Brent Turner, chief digital officer
Home 3-D Printers Take Us on a Maddening Journey into Another Dimension
Testing several home 3-D printers reveals them to be plagued by technical glitches that make the dream of home manufacturing a distant one.
—Tom Simonite, senior IT editor
Video: Ylvis-The Fox
This video is the best thing to hit the Internet in the past three days, hands down.
—Jane Allen, project manager
“How Can They Be So Good?”: The Strange Story of Skype
Quite liked this deep dive on the history of Skype.
—David Talbot, chief correspondent
How to Build Little Doors Inside Your Shell: The Secrets of Snail Carpentry
Snails prep for fall and winter by building tiny walls inside their shells. It reminds me of the work of Angela Belcher (upcoming EmTech MIT speaker), who designs materials inspired by nature.
—David Sweeney, marketing communications manager
Why I’m Never Going Back to Penny Arcade Expo
This article is about Penny Arcade (a Web comic), its cofounder Mike Krahulik, and the backlash against its response to criticism that one of its comics featured a rape joke that the company’s cofounder continues to defend and perpetuate with merchandise.
—Emily Dunkle, user interface/digital designer
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.